Back to results
US 2023/0414676 A1Published application
Liver disease regulatory formulation and use thereof
AssigneeShanghai Celliver Biotechnology Co., Ltd.
InventorsHongdan ZHANG, Xuejing ZHU, Renjie HUANG
Life of this patent
Estimating the term…
Abstract
An objective of the present invention is to provide a liver disease regulatory formulation, which is beneficial to prevent the occurrence and development of a chronic liver disease by remodeling a liver regeneration microenvironment. The liver disease regulatory formulation, comprises a hepatocyte-derived liver progenitor cell or a secretory supernatant of the hepatocyte-derived liver progenitor cell.
Claims30
A liver disease regulatory formulation, comprising a hepatocyte-derived liver progenitor cell or a secretory supernatant of the hepatocyte-derived liver progenitor cell.
Dependencies are inferred from the claim text.